Primary Testicular Lymphoma

Clinical Oncology

Volumn 24, Issue 5, 2012, Pages 358-365

  Ahmad, S S ^a   Idris, S F ^a   Follows, G A ^a   Williams, M V ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Extra nodal lymphoma; Primary testicular lymphoma; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE; VINDESINE;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RELAPSE; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; ORCHIECTOMY; ORCHITIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TESTIS LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TESTIS CANCER; TREATMENT RESPONSE;

HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; TESTICULAR NEOPLASMS;

EID: 84863413521     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.02.005     Document Type: Article

References (62)

1. Zucca E., Conconi A., Mughal T.I., et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003, 21(1):20-27.
2. Gundrum J.D., Mathiason M.A., Moore D.B., Go R.S. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol 2009, 27(31):5227-5232.
3. Lantz A.G., Power N., Hutton B., Gupta R. Malignant lymphoma of the testis: a study of 12 cases. Can Urol Assoc J 2009, 3(5):393-398.
4. Moller M.B., d'Amore F., Christensen B.E. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer 1994, 30A(12):1760-1764.
5. Leite K.R., Garicochea B., Srougi M., et al. Monoclonality of asynchronous bilateral lymphoma of the testis. Eur Urol 2000, 38(6):774-777.
6. Sampat M.B., Sirsat M.V., Kamat M.R. Malignant lymphoma of the testis in Indians. Br J Urol 1974, 46(5):569-575.
7. Vural F., Cagirgan S., Saydam G., Hekimgil M., Soyer N.A., Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc 2007, 99(11):1277-1282.
8. Shahab N., Doll D.C. Testicular lymphoma. Semin Oncol 1999, 26(3):259-269.
9. Pectasides D., Economopoulos T., Kouvatseas G., et al. Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the Hellenic Cooperative Oncology Group experience. Oncology 2000, 58(4):286-292.
10. Fonseca R., Habermann T.M., Colgan J.P., et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer 2000, 88(1):154-161.
11. Crellin A.M., Hudson B.V., Bennett M.H., Harland S., Hudson G.V. Non-Hodgkin's lymphoma of the testis. Radiother Oncol 1993, 27(2):99-106.
12. Soh E., Berman L.H., Grant J.W., Bullock N., Williams M.V. Ultrasound-guided core-needle biopsy of the testis for focal indeterminate intratesticular lesions. Eur Radiol 2008, 18(12):2990-2996.
13. Touroutoglou N., Dimopoulos M.A., Younes A., et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol 1995, 13(6):1361-1367.
14. Al-Abbadi M.A., Hattab E.M., Tarawneh M.S., Amr S.S., Orazi A., Ulbright T.M. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases. Mod Pathol 2006, 19(12):1521-1527.
15. Li D., Xie P., Mi C. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype. Pathol Res Pract 2010, 206(9):611-615.
16. Kemmerling R., Stintzing S., Muhlmann J., Dietze O., Neureiter D. Primary testicular lymphoma: a strictly homogeneous hematological disease?. Oncol Rep 2010, 23(5):1261-1267.
17. Booman M., Douwes J., Glas A.M., de Jong D., Schuuring E., Kluin P.M. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics. J Pathol 2006, 210(2):163-171.
18. Licci S., Morelli L., Covello R. Primary mantle cell lymphoma of the testis. Ann Hematol 2011, 90(4):483-484.
19. Sugimoto K., Koike H., Esa A. Plasmablastic lymphoma of the right testis. Int J Urol 2011, 18(1):85-86.
20. Moertel C.L., Watterson J., McCormick S.R., Simonton S.C. Follicular large cell lymphoma of the testis in a child. Cancer 1995, 75(5):1182-1186.
21. Ferry J.A., Harris N.L., Young R.H., Coen J., Zietman A., Scully R.E. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994, 18(4):376-390.
22. Stefanovic A., Lossos I.S. Primary testicular lymphoma: the site matters. Leuk Lymphoma 2010, 51(7):1159-1160.
23. Drillenburg P., Pals S.T. Cell adhesion receptors in lymphoma dissemination. Blood 2000, 95(6):1900-1910.
24. Booman M., Szuhai K., Rosenwald A., et al. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. J Pathol 2008, 216(2):209-217.
25. Zouhair A., Herrmann E., Ugurluer G., Gaye P.M., Mirimanoff R.O., Ozsahin M. Primary testicular lymphoma. Swiss Med Wkly 2010, 140:w13076.
26. Mazloom A., Fowler N., Medeiros L.J., Iyengar P., Horace P., Dabaja B.S. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leuk Lymphoma 2010, 51(7):1217-1224.
27. Seymour J.F., Solomon B., Wolf M.M., Janusczewicz E.H., Wirth A., Prince H.M. Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. Clin Lymphoma 2001, 2(2):109-115.
28. Riemersma S.A., Jordanova E.S., Schop R.F., et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 2000, 96(10):3569-3577.
29. Booman M., Douwes J., Glas A.M., et al. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma. Clin Cancer Res 2006, 12(9):2698-2705.
30. Bart J., Groen H.J., van der Graaf W.T., et al. An oncological view on the blood-testis barrier. Lancet Oncol 2002, 3(6):357-363.
31. Ikeda Y., Nakazawa S., Kudo M. Intracranial malignant lymphoma developing 20 years after total removal of testicular malignant lymphoma - case report. Neurol Med Chir (Tokyo) 1986, 26(1):68-70.
32. Lagrange J.L., Ramaioli A., Theodore C.H., et al. Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol 2001, 12(9):1313-1319.
33. Vitolo U., Ferreri A.J., Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol 2008, 65(2):183-189.
34. Vitolo U., Chiappella A., Ferreri A.J., et al. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. J Clin Oncol 2011, 29(20):2766-2772.
35. Buskirk S.J., Evans R.G., Banks P.M., O'Connell M.J., Earle J.D. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys 1982, 8(10):1699-1703.
36. Martenson J.A., Buskirk S.J., Ilstrup D.M., et al. Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol 1988, 6(2):297-302.
37. Read G. Lymphomas of the testis - results of treatment 1960-77. Clin Radiol 1981, 32(6):687-692.
38. Visco C., Medeiros L.J., Mesina O.M., et al. Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?. Clin Lymphoma 2001, 2(1):40-46.
39. Darby S., Hancock B.W. Localised non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol 2005, 26(4):1093-1099.
40. Linassier C., Desablens B., Lefrancq T., et al. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group. Clin Lymphoma 2002, 3(3):167-172.
41. Telio D., Villa D., Shenkier T., et al. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era. Blood (ASH Annual Meeting Abstracts) 2011, 118-780.
42. Larouche J.F., Bergeron M., Hampson G., Illidge T., Delage R. Rituximab cerebrospinal fluid levels in patients with primary central nervous system lymphoma treated with intravenous high dose rituximab. Blood (ASH Annual Meeting Abstracts) 2011, 118-1644.
43. Aviles A., Nambo M.J., Cleto S., Neri N., Huerta-Guzman J. Rituximab and dose-dense chemotherapy in primary testicular lymphoma. Clin Lymphoma Myeloma 2009, 9(5):386-389.
44. Park B.B., Kim J.G., Sohn S.K., et al. Consideration of aggressive therapeutic strategies for primary testicular lymphoma. Am J Hematol 2007, 82(9):840-845.
45. Hasselblom S., Ridell B., Wedel H., Norrby K. Sender Baum M, Ekman T. Testicular lymphoma - a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol 2004, 43(8):758-765.
46. Ackland S.P., Schilsky R.L. High-dose methotrexate: a critical reappraisal. J Clin Oncol 1987, 5(12):2017-2031.
47. Aviles A., Neri N., Huerta-Guzman J., Perez F., Fernandez R. Testicular lymphoma: organ-specific treatment did not improve outcome. Oncology 2004, 67(3-4):211-214.
48. Harder H., Holtel H., Bromberg J.E., et al. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 2004, 62(4):544-547.
49. Correa D.D., Rocco-Donovan M., DeAngelis L.M., et al. Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J Neurooncol 2009, 91(3):315-321.
50. Wielinga P.R., Westerhoff H.V., Lankelma J. The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells. Eur J Biochem 2000, 267(3):649-657.
51. Zelenetz A.D., Advani R.H., Byrd J.C., et al. Non-Hodgkin's lymphomas. J Natl Compr Canc Netw 2008, 6(4):356-421.
52. Cheson B.D., Horning S.J., Coiffier B., et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999, 17(4):1244.
53. Mason M.D., Featherstone T., Olliff J., Horwich A. Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy. Clin Oncol (R Coll Radiol) 1991, 3(3):147-150.
54. Classen J., Schmidberger H., Meisner C., et al. Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German Testicular Cancer Study Group (GTCSG). Br J Cancer 2004, 90(12):2305-2311.
55. Fossa S.D., Horwich A., Russell J.M., et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999, 17(4):1146.
56. Lowry L., Smith P., Qian W., et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011, 100(1):86-92.
57. Conrad A.L., Go R.S. Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma. Eur J Haematol 2009, 83(6):603-605.
58. Riccardi R., Vigersky R.A., Barnes S., Bleyer W.A., Poplack D.G. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res 1982, 42(5):1617-1619.
59. Centola G.M., Keller J.W., Henzler M., Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 1994, 15(6):608-613.
60. Rowley M.J., Leach D.R., Warner G.A., Heller C.G. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974, 59(3):665-678.
61. Giwercman A., von der Maase H., Berthelsen J.G., Rorth M., Bertelsen A., Skakkebaek N.E. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991, 73(3):596-603.
62. Petersen P.M., Giwercman A., Daugaard G., et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 2002, 20(6):1537-1543.